EntreMed to Present at the New York Society of Security Analysts Industry Conference
November 25 2008 - 7:00AM
PR Newswire (US)
ROCKVILLE, Md., Nov. 25 /PRNewswire-FirstCall/ -- EntreMed, Inc.
(NASDAQ: ENMD), a clinical-stage pharmaceutical company developing
therapeutics for the treatment of cancer and inflammatory diseases,
announced today that a Company overview will be provided at the
NYSSA 2008 Biotech and Specialty Pharmaceuticals Industry
Conference, to be held at the Conference Facilities at the NYSSA,
New York, December 2, 2008. Dane R. Saglio, Chief Financial
Officer, will present on behalf of the Company. The presentation is
scheduled for 1:35 p.m. (local time) and will be included in an
archived web cast on the NYSSA web site after December 3, 2008. An
electronic version of Mr. Saglio's presentation will be available
on the Company's web site at http://www.entremed.com/. (LOGO:
http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO) About
EntreMed EntreMed, Inc. is a clinical-stage pharmaceutical company
developing therapeutic candidates primarily for the treatment of
cancer and inflammation. MKC-1, an oral cell-cycle regulator with
activity against the mTOR pathway, is currently in multiple Phase 2
clinical trials for cancer. ENMD-2076, a selective angiogenic
kinase inhibitor, and ENMD-1198, a novel antimitotic agent are in
Phase 1 studies in advanced cancers. The Company also has an
approved IND application for Panzem(R) in rheumatoid arthritis.
EntreMed's goal is to develop and commercialize new compounds based
on the Company's expertise in angiogenesis, cell cycle regulation,
cell signaling and inflammation - processes vital to the treatment
of cancer and other diseases, such as rheumatoid arthritis.
Additional information about EntreMed is available on the Company's
web site at http://www.entremed.com/ and in various filings with
the Securities and Exchange Commission. Ginny Dunn Associate
Director Corporate Communications & Investor Relations
EntreMed, Inc. 240-864-2643
http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO
http://photoarchive.ap.org/ DATASOURCE: EntreMed, Inc. CONTACT:
Ginny Dunn, Associate Director, Corporate Communications &
Investor Relations, of EntreMed, Inc., +1-240-864-2643 Web Site:
http://www.entremed.com/
Copyright